Novo Holdings A/S

Novo Holdings A/S reported 27 holdings worth US$1.49B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Novo Holdings A/S reported 27 holdings worth US$1.49B as of Sep 30, 2026. Largest: Edgewise Therapeutics, Inc., ASML Holding NV and Brookfield Corporation. Filed Nov 16, 2026 (Form 13F).

Holdings
27
Value as reported
US$1.49B

The filing in full

CompanySharesValue as reported% of portfolio
Edgewise Therapeutics, Inc.5.35MUS$217M14.6%
ASML Holding NV94,946US$172M11.5%
Brookfield Corporation4.47MUS$163M10.9%
Hemab Therapeutics Holdings, Inc.4.18MUS$129M8.7%
Avalyn Pharma Inc.3.45MUS$98.3M6.6%
Mirum Pharmaceuticals, Inc.1.13MUS$96.2M6.5%
Salesforce, Inc.393KUS$90.3M6.1%
Enliven Therapeutics, Inc.1MUS$45.8M3.1%
4D Molecular Therapeutics, Inc.3MUS$42.9M2.9%
Obsidian Therapeutics, Inc.3.12MUS$42.9M2.9%
Vaxcyte, Inc.710KUS$40.4M2.7%
Floor & Decor Holdings, Inc.797KUS$36.5M2.5%
Viridian Therapeutics, Inc.1.75MUS$36M2.4%
ArriVent BioPharma, Inc.1.18MUS$35.6M2.4%
Insmed Incorporated284KUS$32.5M2.2%
Celldex Therapeutics, Inc.950KUS$30.8M2.1%
Alibaba Group Holding Limited257KUS$27.7M1.9%
Xenon Pharmaceuticals Inc.652KUS$24.3M1.6%
Scholar Rock Holding Corporation460KUS$22.2M1.5%
Dyne Therapeutics, Inc.1.38MUS$22.2M1.5%
MapLight Therapeutics, Inc.2.09MUS$21.3M1.4%
Contineum Therapeutics, Inc.704KUS$9.45M0.63%
Alumis Inc.1.25MUS$9.24M0.62%
BridgeBio Oncology Therapeutics, Inc.2.25MUS$9.22M0.62%
Marqeta, Inc.110KUS$1.88M0.13%
LanzaTech Global, Inc.158KUS$903K0.06%
Crinetics Pharmaceuticals, Inc.0US$00.00%

Source

Download original · View original at SEC

Related